Cargando…

Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy

Severe thrombocytopenia (≤50×10(9) platelets/L) due to hematological malignancy and intensive chemotherapy is associated with an increased risk of clinically significant bleeding. Since the bleeding risk is not linked to the platelet count only, other hemostatic factors must be involved. We studied...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baaten, Constance C. F. M. J., Moenen, Floor C. J. I., Henskens, Yvonne M. C., Swieringa, Frauke, Wetzels, Rick J. H., van Oerle, René, Heijnen, Harry F. G., ten Cate, Hugo, Holloway, Graham P., Beckers, Erik A. M., Heemskerk, Johan W. M., van der Meijden, Paola E. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119160/ https://www.ncbi.nlm.nih.gov/pubmed/29880611 http://dx.doi.org/10.3324/haematol.2017.185165

Ejemplares similares

The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study
por: Gulpen, Anouk J. W., et al.
Publicado: (2019)

Preoperative screening for bleeding disorders: A comprehensive laboratory assessment of clinical practice
por: Vries, Minka J., et al.
Publicado: (2018)

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
por: Henskens, Yvonne M. C., et al.
Publicado: (2018)

Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time
por: Heubel‐Moenen, Floor C. J. I., et al.
Publicado: (2022)

Integrating platelet and coagulation activation in fibrin clot formation
por: Swieringa, Frauke, et al.
Publicado: (2018)

Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1
por: De Simone, Ilaria, et al.
Publicado: (2022)

Whole Blood Based Multiparameter Assessment of Thrombus Formation in Standard Microfluidic Devices to Proxy In Vivo Haemostasis and Thrombosis
por: Provenzale, Isabella, et al.
Publicado: (2019)

Assessment of a complete and classified platelet proteome from genome-wide transcripts of human platelets and megakaryocytes covering platelet functions
por: Huang, Jingnan, et al.
Publicado: (2021)

Platelet Dysfunction in Thrombosis Patients Treated with Vitamin K Antagonists and Recurrent Bleeding
por: van der Meijden, Paola E. J., et al.
Publicado: (2013)

Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa
por: van de Berg, Tom W., et al.
Publicado: (2023)

PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.
por: Monard, Amaury, et al.
Publicado: (2023)

Platelet Membrane Receptor Proteolysis: Implications for Platelet Function
por: Wu, Jiayu, et al.
Publicado: (2021)

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy
por: de Breet, C. P. D. M., et al.
Publicado: (2021)

Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
por: Grottke, Oliver, et al.
Publicado: (2013)

Effects of Platelet Agonists and Priming on the Formation of Platelet Populations
por: Veninga, Alicia, et al.
Publicado: (2021)

Key role of integrin α(IIb)β(3) signaling to Syk kinase in tissue factor-induced thrombin generation
por: van der Meijden, Paola E. J., et al.
Publicado: (2012)

Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity
por: Kuiper, Gerhardus J. A. J. M., et al.
Publicado: (2016)

Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse events
por: Olie, R. H., et al.
Publicado: (2021)

Clonal hematopoietic mutations linked to platelet traits and the risk of thrombosis or bleeding
por: Veninga, Alicia, et al.
Publicado: (2020)

Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation
por: Brouns, Sanne L. N., et al.
Publicado: (2020)

Rotational Thromboelastometry in High-Risk Patients on Dual Antithrombotic Therapy After Percutaneous Coronary Intervention
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

GPVI expression is linked to platelet size, age, and reactivity
por: Veninga, Alicia, et al.
Publicado: (2022)

Role of Platelet Glycoprotein VI and Tyrosine Kinase Syk in Thrombus Formation on Collagen-Like Surfaces
por: Jooss, Natalie J., et al.
Publicado: (2019)

Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease
por: Olie, Renske H., et al.
Publicado: (2019)

The hypercoagulable profile of patients with stent thrombosis
por: Loeffen, R, et al.
Publicado: (2015)

Identification of platelet function defects by multi-parameter assessment of thrombus formation
por: de Witt, Susanne M., et al.
Publicado: (2014)

Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study
por: Post, Demi S., et al.
Publicado: (2022)

Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability
por: van de Berg, Tom W., et al.
Publicado: (2021)

CKD Effects on Platelets: Implications for Cardiovascular Risk
por: Baaten, Constance C.F.M.J., et al.
Publicado: (2022)

Endothelial Cell Dysfunction and Increased Cardiovascular Risk in Patients With Chronic Kidney Disease
por: Baaten, Constance C.F.M.J., et al.
Publicado: (2023)

High-throughput elucidation of thrombus formation reveals sources of platelet function variability
por: van Geffen, Johanna P., et al.
Publicado: (2019)

Potential value of the calibrated automated thrombogram in patients after a cerebral venous sinus thrombosis; an exploratory study
por: van der Bruggen, Myrthe M., et al.
Publicado: (2021)

Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort
por: van de Berg, Tom W., et al.
Publicado: (2022)

Vitamin K antagonist use induces calcification and atherosclerotic plaque progression resulting in increased hypercoagulability
por: van Gorp, Rick H, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura secondary to Streptococcus
por: Morrin, M.J., et al.
Publicado: (2006)

Differential Impact of Cytochrome 2C19 Allelic Variants on Three Different Platelet Function Tests in Clopidogrel-Treated Patients
por: Olie, Renske H., et al.
Publicado: (2021)

Differential Fibrinolysis Profile in COVID-19 Patients Dependent on Immunosuppressive Treatment Regimen: A Nested Case-Control Study
por: Nagy, Magdolna, et al.
Publicado: (2022)

Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review
por: Harlacher, Eva, et al.
Publicado: (2022)

Reversible Platelet Integrin αIIbβ3 Activation and Thrombus Instability
por: Zou, Jinmi, et al.
Publicado: (2022)

Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro
por: Brinkman, Herm Jan M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jiauvsoaf0kr4uggloriiip49i